About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
Statement of Purpose
Guidelines for Authors
Health Care and Law
Methadone is gaining renewed interested as a therapy for chronic pain as well as for opioid dependence. The authors discuss safety concerns, two legal cases that resulted from patients’ deaths, and risk–management issues for P&T committees to consider.
James O’Donnell, PharmD, MS; and F. Randy Vogenberg, RPh, PhD
62nd Annual Meeting of the American Association For the Study of Liver Diseases and American College of Rheumatology Annual Meeting
Topics covered at "Liver Week" included alisporivir and a protease inhibitor (BI 201335) for hepatitis C virus infection; everolimus for liver transplantation, and telaprevir in cirrhosis. The rheumatology sessions addressed the small molecule apremilast for psoriatic arthritis; etanercept for rheumatoid arthritis; and abatacept, adalimumab, etanercept, and infliximab in rheumatoid arthritis.
The Oncologist's Perspective
New findings reveal that patients with breast, prostate, and colon cancers are increasingly being treated in outpatient settings instead of hospitals; most cancer patients have early-stage disease upon diagnosis, except for Medicaid recipients; and oncologists have concerns about decreasing net profits.
Janice Zoeller and Peter Sonnenreich, MA
Continuing Education Credit
Four second-generation antipsychotic medications — paliperidone (Invega), iloperidone (Fanapt), asenapine (Saphris), and lurasidone (Latuda) — may offer useful options for patients with schizophrenia, schizoaffective disorder, and bipolar disorder as well as depression.
Jonathan R. Scarff, MD; and David A. Casey, MD
Matthew Grissinger, RPh, FASCP
Pharmacists to Play a Secondary Role in New Physician–Hospital Organizations
Hospital pharmacists will be dealing with the fallout from cost-shifting in ACOs — with none of the benefits
FDA approvals, drug indications, and updates
Deferiprone (Ferriprox) for iron overload after blood transfusions; and ezogabine (Potiga) for partial-onset seizures
Marvin M. Goldenberg, PhD, RPh, MS
Linagliptin (Tradjenta) for type-2 diabetes mellitus
Maisha Kelly Freeman, PharmD, MS, BCPS